After Russia announced it has developed the world's first vaccine against Covid-19, the Indian Embassy in Moscow has been in touch with the Russian Medical Research Institute, as per an Indian Express report citing government sources.
“The Indian Mission is engaging separately with the Russian side through our embassy in Moscow. We are now awaiting the safety and efficacy data of this vaccine for Covid-19,” a source said.
Last week, Russian President Vladimir Putin said that country's Ministry of Health green-lighted the Sputnik V vaccine developed by the Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology.
President Putin also said one of his daughters was among the candidates who had been inoculated with it.
Russia’s vaccine Sputnik V (Gam-COVID-Vac Lyo) is based on the DNA of a SARS-CoV-2 type adenovirus, a common cold virus. The vaccine uses the weakened virus to deliver small parts of a pathogen and stimulate an immune response. Russia has so far made public the results of phase-I of the clinical trials involving 76 volunteers, with majority recruited from the military. Half of the participants were injected with a vaccine in liquid form and the other half with a vaccine that came as soluble powder.
It was also reported earlier that the third stage of the research on the world's first registered vaccine against the novel coronavirus, called Sputnik V, may begin in 7-10 days.
“Phase 3 clinical trial involving more than 2,000 people in Russia, a number of Middle Eastern (UAE and Saudi Arabia), and Latin American countries (Brazil and Mexico) will start on August 12”, the official Sputnik V website, run by the Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) says.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.